GLP-1 before and after
You are getting oriented.
Reference and calculator, not medical advice. Dosing figures below are transcribed from FDA-approved prescribing information and link back to it. Last reviewed August 2026.
Before-and-after photographs carry almost no transferable information, and it is worth being specific about why rather than just cautioning against them. They omit every variable that determines the outcome: starting point, dose reached, time elapsed, what else changed, and whether the person is representative of anyone. Two photographs with none of that attached are compatible with almost any underlying story.
There is one thing they do reliably convey, which is that a timeline exists. The approved schedules step upward over months precisely because escalation speed drives most of what people experience. Anyone whose images span a short period was, by the structure of the schedules, still early in that process — which is the single most useful thing to read off a set of photos.
Wegovy titration schedule
Semaglutide · once weekly · subcutaneous injection · as published in the prescribing information
| Step | Dose | Notes |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Starting dose |
| Weeks 5–8 | 0.5 mg | — |
| Weeks 9–12 | 1 mg | — |
| Weeks 13–16 | 1.7 mg | — |
| Week 17+ | 2.4 mg | Maintenance dose |
This is the labelled default. Holding at a step longer than shown is common practice and is a decision for your prescriber. Transcribed from the Wegovy prescribing information (label revised 30 June 2026); checked against that label on 7 August 2026.
Common questions
- How long until results?
- Not something this site will estimate — it is individual and depends on factors no page can see. What the labels do define is the escalation timeline, which sets a floor on how long reaching a maintenance dose takes.
- Are the photos in ads real?
- Promotional imagery is marketing material and is selected. The absence of dose, duration and starting point makes any single set uninformative regardless of authenticity.
Sources and last review
Every dosing figure on this page is transcribed from an FDA-approved label and links back to it. Conversions are arithmetic you can repeat by hand. Nothing here is reviewed by a clinician, and this site does not employ one — which is exactly why what I do publish stays traceable to its source.
- Wegovy (Semaglutide) prescribing information — Novo Nordisk, label revised 30 June 2026, checked 7 August 2026
Transcribed from the labels above and checked by me — Gavin, who builds this site, takes a GLP-1, and is not a clinician. Last reviewed August 2026. Found an error? [email protected] — I treat corrections as bugs. How this site is built and funded.